REG - Integrated Diag Hdgs - Annual Financial Report

Integrated Diagnostics HoldingsAnnouncement

04/04/2024 14:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240404:nRSD3746Ja&default-theme=true

RNS Number : 3746J  Integrated Diagnostics Holdings PLC  04 April 2024

Integrated Diagnostics Holdings plc

 (the "Company")

 

Annual Financial Report

Following the announcement on 28 March 2024 of its full year results for the
year ended 31 December 2023 (RNS number: 6093I), the Company announces that
it has published the 2023 Annual Report and Accounts ("2023 Annual Report") on
the Company's
website: https://investors.idhcorp.com/en/reports-and-presentations
(https://investors.idhcorp.com/en/reports-and-presentations) .

 

In accordance with Listing Rule 14.3.6, the 2023 Annual Report has also been
submitted to the National Storage Mechanism and will shortly be available for
inspection at https://data.fca.org.uk/#/nsm/nationalstoragemechanism
(https://data.fca.org.uk/#/nsm/nationalstoragemechanism) .

 

The Company confirms that, in compliance with DTR 6.3.5 R (1A), the regulated
information required under DTR 6.3.5, is available in unedited full text
within the 2023 Annual Report available on the National Storage Mechanism and
in compliance with DTR 6.3.5 (3) is available on the Company's website (see
above).

 

 For further information please contact:

 

 Integrated Diagnostics Holdings plc

 Tarek Yehia                          +20(0)1068826678

 Investor Relations Director

 Company Secretary                    IDHLondon@linkgroup.co.uk

 Link Company Matters Limited

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  ACSSSLFELELSEIL